Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy The Netherlands Norway Spain
  • Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Finland Germany The Netherlands Norway +2
  • Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia Denmark France Germany Hungary Italy +5
  • Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Hungary Italy The Netherlands Norway +2